We are a patient-focused team of trailblazers dedicated to realizing the potential of microglia biology to deliver life-changing therapeutics

MANAGEMENT

Featured

Ivana Magovčević-Liebisch, PhD, JD

President & Chief Executive Officer

David Gray, PhD

Chief Science Officer

Petra Kaufmann, MD, FAAN

Chief Medical Officer

Featured

Evan Thackaberry, PhD, DABT

SVP, Head of Early Development

Jennifer Ziolkowski, CPA

Chief Financial Officer

OUR TEAM

Featured

Abigail Renoux, PhD

Principal Scientist, Discovery Biology

Adrianus Martens, MBA

Associate Director, FP&A

Ali Toumadj, PharmD

VP, Head of Medical Sciences

Alysia Martins, MSE

Principal Research Associate, Discovery Biology

Anadina Garcia, MBS, LATG

Associate Director, Nonclinical Operations

Andrea Abdula

Associate Director, Quality Assurance GMP

April Effort, MS, MBA

VP, Head of Corporate Development

Archie Bright

Senior AP Analyst & Accountant

Ben Raynak

Senior Director, Contracts

Beril Kiragasi, PhD

Senior Scientist, Discovery Biology

Bhaumik Pandya, PhD

Senior Director, Chemistry

Borislav Dejanovic, PhD

Senior Director, Translational Sciences & External Innovation

Brittanie Walters, CPA

Accounting Manager

Charles Democko

SVP, Regulatory Affairs & Quality

Christian Mirescu, PhD

SVP, Head of Neuroimmunology

Clarissa Martinez-Rubio, PhD

Associate Director, Patient Advocacy

Cynthia Cassandro, BS, RN

VP, Patient Advocacy & Engagement

Denise Modoono

Executive Assistant

Denitza Raitcheva

Associate Director, Clinical Biomarkers & Translational Medicine

Donald McLaren, PhD

Senior Director, Clinical Biomarkers & Translational Medicine

Dwayne Stanley, MBA, PMP

Senior Director, Program Management

Elizabeth Thompson

Senior Director, Data Management

Eric Brophy

Senior Manager, Information Technology

Evangelia Hatzis, PhD, PMP

VP, Program Management

Francois Gaudreault, PhD

VP, Clinical Pharmacology

Frederick Gergits

Scientist, Discovery Biology

Hannah Tucker

Senior Regulatory Affairs Associate

Heidi Mizenko, MBA

Senior Human Resources Associate

Humann Hodjatzadeh, MBA

VP, Financial Planning & Analysis

Jade Clarkson

Clinical Trial Manager

BOARD OF DIRECTORS

Featured

Bruce Booth, DPhil

Chairman
Partner, Atlas Venture

Cheryl Blanchard, PhD

President & CEO,
Anika Therapeutics, Inc.

Gerhard Koenig, PhD

CEO, Augustine Therapeutics

Ivana Magovčević-Liebisch PhD, JD

President & CEO,
Vigil Neuroscience, Inc.

Mary Thistle

Independent Director

Samantha Budd Haeberlein, PhD

Independent Director

Stefan Vitorovic

Former Co-Founder & Managing
Director, Vida Ventures

Suzanne Bruhn, PhD

Independent Director

SCIENTIFIC ADVISORY BOARD

Chairman - Marco Colonna, MD
Robert Rock Belliveau Professor of Pathology & Immunology, Washington University

Donna M. Wilcock, PhD
Barbara and Larry Sharpf Professor of Alzheimer's Disease Research, Professor of Neurology, Adjunct Professor of Anatomy, Cell Biology, Physiology

Bradley Hyman, MD, PhD
John B. Penney, Jr. Professor of Neurology, Harvard Medical School; Alzheimer’s Unit Director, MassGeneral Institute for Neurodegenerative Disease; Director, Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital

Beth Hoffman, PhD
Founder, President, and CEO at Origami Therapeutics

Team

We are a patient-focused team of trailblazers dedicated to realizing the potential of microglia biology to deliver life-changing therapeutics

MANAGEMENT

OUR TEAM

BOARD OF DIRECTORS

SCIENTIFIC ADVISORY BOARD